Specialists for Hereditary ATTR amyloidosis

40 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

EMILIE GARRIDO PRADALIE
Rare Disease / Clinical Research
APHM DRIC
PI×13
Mathew S Maurer, MD
Rare Disease / Clinical Research
Columbia University
PI×1
John L Berk, M.D., D.D.S
Rare Disease / Clinical Research
Boston University
CASTRO VALLEY, CA
PI×1
Mazen A Hanna, MD, M.D
Rare Disease / Clinical Research
The Cleveland Clinic
CLEVELAND, OH
PI×3
Torstein Hole, MD, PhD
Rare Disease / Clinical Research
Helse Møre og Romsdal HF and NTNU
PI×1
John Vest, MD, BAS
Rare Disease / Clinical Research
Alnylam Pharmaceuticals
COLORADO SPRINGS, CO
PI×1
Erwan Donal
Rare Disease / Clinical Research
Rennes University Hospital
PI×1 21
Justin Grodin, MD, MD
Rare Disease / Clinical Research
University of Texas Southwestern Medical Center
DALLAS, TX
PI×1
Jan Griffin, MD
Rare Disease / Clinical Research
Medical University of South Carolina
PI×1
Mineyuki Mizuguchi
Rare Disease / Clinical Research
Graduate School of Medicine and Pharmaceutical Sciences
2
Mitsuharu Ueda
Rare Disease / Clinical Research
Kumamoto University
2
Nagaaki Katoh
Rare Disease / Clinical Research
Shinshu University School of Medicine
2
Scott D Solomon
Rare Disease / Clinical Research
Brigham and Women's Hospital
2
Emre Aldinc
Rare Disease / Clinical Research
Alnylam Pharmaceuticals
MA
2
Takeshi Yokoyama
Rare Disease / Clinical Research
Graduate School of Medicine and Pharmaceutical Sciences
2
Mitsuto Sato
Rare Disease / Clinical Research
Shinshu University School of Medicine
2
Philip N Hawkins, DDS
Rare Disease / Clinical Research
National Amyloidosis Centre
MILWAUKEE, WI
2
Laura Obici
Rare Disease / Clinical Research
Amyloidosis Research and Treatment Centre
4
Chongshu Chen
Rare Disease / Clinical Research
Alnylam Pharmaceuticals
3
Chi-Chao Chao
Rare Disease / Clinical Research
National Taiwan University Hospital
3
Michael Polydefkis, M.D
Rare Disease / Clinical Research
Johns Hopkins Hospital
BALTIMORE, MD
4
David Adams
Rare Disease / Clinical Research
Centre Hospitalier Universitaire (CHU) Bicêtre
PI×1 8
Jonas Wixner
Rare Disease / Clinical Research
ublic Health and Clinical Medicine
2
Prajakta Badri
Rare Disease / Clinical Research
Alnylam Pharmaceuticals
2
Rosie Z Yu
Rare Disease / Clinical Research
Ionis Pharmaceuticals
CA
2
T Jesse Kwoh
Rare Disease / Clinical Research
Clinical Development
CA
2
Nicholas J Viney
Rare Disease / Clinical Research
Clinical Development
CA
2
Jersey Chen, MD
Rare Disease / Clinical Research
Late-Stage Development
GAITHERSBURG, MD
2
Márcia Waddington Cruz
Rare Disease / Clinical Research
Hospital Universitário Clementino Fraga Filho
2
Yusuke Takahashi
Rare Disease / Clinical Research
Shinshu University School of Medicine
SPRINGFIELD, MO
3
Omar Abou Ezzeddine
Cardiology
Mayo Clinic
QC-verified PI×1NORD CoE
Matthew T White
Rare Disease / Clinical Research
Alnylam Pharmaceuticals
NORWOOD, MA
3
Kon-Ping Lin
Rare Disease / Clinical Research
Taipei Veterans General Hospital
2
Yoshiki Sekijima
Rare Disease / Clinical Research
Shinshu University School of Medicine
7
Violaine Planté-Bordeneuve
Rare Disease / Clinical Research
East Paris University
2
Mary M Reilly
Rare Disease / Clinical Research
UCL Queen Square Institute of Neurology
3
Akira Matsushima
Rare Disease / Clinical Research
JA Nagano Koseiren Kakeyu Misayama Rehabilitation Center Kakeyu Hospital
3
Yusuke Mochizuki
Rare Disease / Clinical Research
Shinshu University School of Medicine
4
Ken Takasone
Rare Disease / Clinical Research
Shinshu University School of Medicine
3
Simina Ticau
Rare Disease / Clinical Research
Alnylam Pharmaceuticals
MA
2

More about Hereditary ATTR amyloidosis